Extracellular galectin-3 tracks activated, antigen-experienced T cells across mouse and human data
Galectin-3 is emerging as more than a soluble inflammatory mediator. In this study, it behaved like a selective marker of T cells that had already crossed into an activated or memory-like state, and it did so in a context-dependent fashion across age, tissue site, sex, strain, and circadian timing. In mice, Gal-3-associated CD4+ and CD8+ T cells were not randomly distributed; they clustered in biologically meaningful compartments and carried a phenotype consistent with prior antigen exposure and ongoing immune engagement.
The finding matters because T cells are not passive recipients of galectin signaling. They may also display and acquire extracellular Gal-3 in ways that shape their own function. The work points to a bidirectional relationship in which activated T cells acquire Gal-3 from their environment, or possibly participate in its presentation, while Gal-3 in turn associates with receptors and signaling proteins that can alter survival and responsiveness.
One result stood out immediately: Gal-3-positive T cells were more activated, more proliferative, and more prone to apoptosis.
Memory-phenotype T cells carried the strongest Gal-3 signature
Across murine tissues, Gal-3-positive T cells showed elevated activation markers and stronger evidence of T-cell receptor-linked signaling. They also expressed higher levels of cytolytic mediators and markers tied to proliferation, while apoptosis was increased rather than reduced. This combination is not typical of quiescent lymphocytes. It is more consistent with cells that have been repeatedly stimulated, are metabolically engaged, and may be nearing a stage where activation-driven cell death limits further expansion.
The phenotype extended into memory compartments. Gal-3-positive cells were enriched within central memory and effector memory subsets, and they expressed higher levels of co-inhibitory receptors, including PD-1. ImageStream analysis confirmed co-expression of Gal-3 with PD-1, providing spatial support for what the flow data suggested. In practical terms, that places Gal-3 in the same cellular neighborhood as molecules that often accompany chronic stimulation, exhaustion-like states, and dampened effector durability.
This is a useful biological clue. Memory-phenotype T cells sit at the intersection of persistence and restraint; they are capable of rapid recall but remain vulnerable to exhaustion or attrition when the stimulation burden becomes sustained. Gal-3 appears to identify that interface rather than a broad T-cell population.
CD44 and PD-1 emerged as plausible binding partners on activated cells
Recombinant Gal-3 preferentially bound activated T cells, not resting cells. Binding was associated with CD44 and CD3, which supports an activation-dependent acquisition of extracellular Gal-3 on the T-cell surface. CD44 is a logical candidate here because it is a heavily glycosylated adhesion and signaling molecule that changes with activation and memory differentiation. Once glycan structures shift, lectin binding becomes more likely, and the cell surface itself becomes a moving scaffold for immune regulation.
Interference experiments strengthened that interpretation. Antibody blockade of CD44 and exposure to lactose, which can compete for galectin binding, were used to disrupt this interaction in selected assays. The overall design makes the central point hard to miss: Gal-3 binding is not a fixed property of all T cells. It depends on the activation state of the cell and the molecular architecture of the surface it presents.
A key implication follows from that surface biology. If activated T cells acquire Gal-3 preferentially, then Gal-3 may function less like a global plasma marker and more like a selective molecular tag for cells already engaged in antigen experience.
The intracellular source appears limited, shifting attention to the extracellular pool
The investigators also examined whether T cells themselves are a major source of Gal-3. Intracellular staining argued against that idea. T cells are unlikely to be the dominant source of Gal-3 in these systems, which pushes attention toward extracellular production and uptake from surrounding immune or stromal cells.
That distinction changes how the biology should be read. If T cells are mainly binding or displaying Gal-3 acquired from outside, then the lectin may be functioning as part of a local inflammatory circuit rather than as a canonical T-cell product. Macrophages, dendritic cells, epithelial cells, fibroblasts, and other tissue-resident cells are all plausible contributors to this pool in inflamed settings. In that arrangement, activated T cells would not simply express their own regulatory molecule; they would become marked by the tissue environment they are traversing.
Human transcriptomic datasets matched the murine phenotype
Re-analysis of human thymocyte and Long COVID single-cell RNA sequencing datasets supported the same broad pattern. LGALS3 expression aligned with activated and exhausted T-cell states rather than resting developmental intermediates. The human data do not erase the complexity of thymic biology or chronic post-viral immune remodeling, but they do extend the mouse findings into clinically relevant human settings.
That cross-species consistency gives the study more than descriptive value. It suggests that Gal-3-associated T-cell states are not a murine artifact and may be relevant to human immune activation, chronic inflammation, and persistent antigen exposure. In a condition such as Long COVID, where immune dysregulation and altered T-cell states remain active areas of investigation, a marker linked to activated or exhausted phenotypes deserves close attention. The dataset does not prove causality, but it does reinforce the idea that Gal-3 expression tracks with T-cell activation programs that endure beyond the acute phase.
Apoptosis, exhaustion-like features, and immune homeostasis converge
The most clinically relevant signal in this paper may be the combination of activation and apoptosis. T cells that are strongly stimulated often face a tradeoff between function and survival. Increased cytolytic machinery and proliferative activity can coexist with heightened susceptibility to cell death, especially when inhibitory receptors such as PD-1 are elevated. Gal-3 may sit within that regulatory tension, marking cells that are active but also biologically vulnerable.
For immunologists, that raises several mechanistic possibilities. Extracellular Gal-3 may stabilize receptor lattices, alter TCR mobility, or bias signaling thresholds in ways that reshape effector output. CD44 and CD3 association point toward a membrane-level mechanism, while the PD-1 connection suggests a broader relationship to inhibitory signaling and antigen-experience. The net effect could be either a brake on overactivation or an amplifier of dysfunctional persistence, depending on tissue context and timing.
The study also reminds clinicians and translational researchers that immune checkpoints are not limited to canonical receptor-ligand pairs. Lectins can function as regulatory modifiers of the T-cell surface itself, and their distribution may be shaped by local inflammation, circadian biology, and developmental stage. Those variables were not decorative details in this work; they were part of the signal.
What this means for immune monitoring and future mechanistic work
This research positions galectin-3 as both a marker and a possible regulator of activated, antigen-experienced T cells. It also complicates the older assumption that Gal-3 biology is driven mainly by myeloid cells or by exogenous experimental addition. The data instead support a model in which activated T cells acquire extracellular Gal-3 through glycan-dependent interactions, particularly through CD44 and PD-1-linked contexts, and then display a phenotype associated with memory differentiation and apoptosis.
Several questions remain open. The current data do not establish whether Gal-3 is simply decorating activated T cells or actively steering their fate in vivo. The work also does not resolve how much of the observed biology depends on tissue origin, chronic inflammatory exposure, or circadian variation. Those gaps matter because the same lectin may behave differently in the thymus, spleen, or inflamed peripheral tissue.
Even so, the study sets a clear mechanistic direction: extracellular Gal-3 is preferentially associated with activated T cells and marks memory-phenotype subsets, while intracellular staining argues that T cells are not the main source. For future work, the most important step will be determining whether this association can be manipulated to change T-cell survival, restraint, or exhaustion in human disease.